Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk-Targeted Behavioral Activation: a Novel Approach to the Management of Treatment-Resistant Depression.

NCT06729580 is registered in ClinicalTrials.gov with McGill University as lead sponsor.

NCT NCT06729580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06729580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk-Targeted Behavioral Activation: a Novel Approach to the Management of Treatment-Resistant Depression.
Lead sponsor
McGill University
Phase
Not applicable
Overall status
Completed
Start date
January 5, 2022
Completion date
October 30, 2023
Enrollment
118 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

treatment resistant depression (trd)